Leonard M. Gralnik

Leonard M. Gralnik

Auto-generated profile, based on publicly available information

Leonard M. Gralnik

Herbert Wertheim College of Medicine, Florida International University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2022 in Cureus
Verified
Journal Article
Open access
GAGameli Anthonio
Gameli Anthonio
FMFayeza Malik
Fayeza Malik
AGArmin Ghomeshi
Armin Ghomeshi
OLOlga Lopez
Olga Lopez
LGLeonard Gralnik
Leonard Gralnik
This is a case report involving a 22-year-old male with a past medical history of Down syndrome and major depressive disorder who, at age 16, became preoccupied with returning to an infant-like state. He experienced a gradual deterioration in his mood over a year and began to show symptoms consistent with catatonia. These symptoms included waxy flexibility, hypokinesis, decreased appetite, mutism, and altered sleep habits. Pharmacologic therapy was initiated, and the patient experienced a waxing and waning pattern of improvement and regression. Over several years, various combinations of antidepressants, benzodiazepines, and second-generation antipsychotics were attempted. The patient and his family discontinued all medications except his benzodiazepine in early 2019 and decided to try electroconvulsive therapy (ECT). After more than 100 sessions of ECT between 2019 and 2022, the patient showed notable improvement in overall mood, and his appetite and sleep completely returned to baseline. His speech, affect, and movement also improved. With ECT, the patient showed the most sustained and substantial improvement in his catatonic symptoms. ECT has been historically shown to improve these types of symptoms in catatonic patients, including those who have Down syndrome. Often, clinicians do not consider the possibility of catatonia in patients with this type of presentation, which is unfortunate as misdiagnosis leads to increased morbidity. Additionally, there has not been much discussion of the optimal length of treatment and the necessity of slowly tapered maintenance therapy in the literature. This case report illustrates how catatonia can be a major cause of developmental regression in patients with Down syndrome and offers an example of a promising management strategy for the treatment of this condition.

1 January 2020 in Clinical Psychology and Special Education
Verified
Journal Article
Open access
DVDaniella Vaclavik
Daniella Vaclavik
MBMichele Bechor
Michele Bechor
AFAdriana Foster
Adriana Foster
LGLeonard M. Gralnik
Leonard M. Gralnik
YBYair Bar-Haim
Yair Bar-Haim
JPJeremy W. Pettit
Jeremy W. Pettit
This article presents the results of a case series to assess the feasibility, acceptability, and clinical promise of transcranial Direct Current Stimulation (tDCS) as an augmentation strategy in clinic referred adolescents. Attention Bias Modification Treatment (ABMT) is a computer-based attention-training protocol designed to reduce rapidly deployed attention orienting to threat and thereby reduce anxiety symptom severity. Studies of ABMT reveal overall small to medium effect sizes. Advances in the neural underpinnings of attention to threat and attention-training protocols suggest the potential of tDCS of the dorsolateral prefrontal cortex (dlPFC) as a novel augmentation strategy to enhance ABMT’s efficacy (ABMT + tDCS). However, tDCS has never been tested in a sample of adolescents with anxiety disorders. Six adolescents with a primary anxiety disorder completed all four ABMT + tDCS sessions. Adverse effects were mild and transient. Adolescents and parents independently reported fair to excellent levels of satisfaction. Impairment ratings of the primary anxiety disorder significantly decreased. Further, electrophysiological data recorded via electroencephalography (EEG) suggested decreases in neural resources allocated to threat. These findings support the feasibility, acceptability, and clinical promise of tDCS as an augmentation strategy in adolescents with anxiety disorders, and provide the impetus for further investigation using randomized controlled designs in larger samples.

19 August 2022 in Cureus
Verified
Journal Article
Open access
CBClaudette Barreto
Claudette Barreto
AIAna Vila Irigoyen
Ana Vila Irigoyen
OLOlga Lopez
Olga Lopez
LGLeonard Gralnik
Leonard Gralnik
We present a case of a 35-year-old female with an extensive history of attention-deficit/hyperactivity disorder (ADHD) who experienced a traumatic sexual and physical assault and later developed post-traumatic stress disorder (PTSD). The patient disclosed that her current medication (Vyvanse) used to treat ADHD has been the only treatment modality that has helped control her intrusive thoughts and nightmares. Decreased dopaminergic receptors are associated with developing PTSD and psychostimulants are known to have an effect of increasing Dopamine release. This case report shows promising results and potential off-label use of psychostimulants for the treatment of PTSD.

16 January 2024 in Psychiatry Research Case Reports
Verified
Journal Article
Open access
MRMona Pari Roshan
Mona Pari Roshan
ADAditi Desai
Aditi Desai
JDJacob M. Dunn
Jacob M. Dunn
SAShanon D. Agbeve
Shanon D. Agbeve
LMLexie Mesa-Morales
Lexie Mesa-Morales
LGLeonard M. Gralnik
Leonard M. Gralnik

13 October 2023
Verified
Book Chapter
Closed access
PDF file
LGLeonard M. Gralnik
Leonard M. Gralnik
JRJose A. Rey
Jose A. Rey